Nuvalent, Inc. (NUVL) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $7.4 billion, Nuvalent, Inc. is a mid-cap company. The stock currently trades at $101.29, down 0.65% today, with a 52-week range of $55.53–$113.02.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-5.85 | $-5.85 | -48.9% | |
| 2024 | $-3.93 | $-3.93 | -81.1% | |
| 2023 | $-2.17 | $-2.17 | -31.5% | |
| 2022 | $-1.65 | $-1.65 | +22.5% | |
| 2021 | $-2.13 | $-2.13 | — |